Calibrium's Debt Round

Calibrium raised a round of funding on December 31, 2013.

Calibrium is an emerging privately held biopharmaceutical company focused on developing a portfolio of novel drug candidates for the treatment of diabetes and related metabolic diseases.…

Articles about Calibrium's Debt Round: